Industry Research Reports

Home > Reports > Service & Software > Modified Proteomics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Modified Proteomics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-07-17

Pages: 182 Pages

Report ld: 6977534

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Modified Proteomics Service Market Size(US$)

CAGR 2026-2032

9.2%

Market Size,2032

USD 1,554

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 915 million

Market Forecast in 2032(Value)

US$ 1,554 million

CAGR

9.2%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Modified Proteomics Service was estimated to be worth US$ 854 million in 2025 and is projected to reach US$ 1554 million, growing at a CAGR of 9.2% from 2026 to 2032.

Modified Proteomics Service refers to specialized research services that systematically identify, quantify, localize, and interpret post-translational modifications (PTMs) of proteins using advanced proteomics technologies. Protein post-translational modifications represent chemical alterations occurring after protein synthesis, including phosphorylation, glycosylation, acetylation, ubiquitination, methylation, lipidation, oxidation, and other regulatory modifications. These modifications play critical roles in controlling protein activity, stability, cellular signaling pathways, and disease progression.

Modified proteomics services typically integrate high-resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS), enrichment strategies, isotope labeling technologies, data-independent acquisition (DIA), advanced bioinformatics, and AI-assisted analytical approaches. Service providers deliver comprehensive solutions covering sample preparation, modification site identification, quantitative analysis, differential modification profiling, pathway interpretation, and biological mechanism discovery.

Compared with conventional proteomics, modified proteomics provides deeper insights into functional changes at the protein level, enabling advanced applications in drug target discovery, disease mechanism investigation, biomarker development, and precision medicine. As pharmaceutical innovation and translational research continue to expand, modified proteomics services have become an essential technology platform supporting modern biomedical research.

The modified proteomics service industry primarily operates under a technology-intensive service model combining advanced analytical platforms, specialized scientific expertise, and bioinformatics capabilities. Service providers establish laboratory infrastructure equipped with high-resolution mass spectrometers, nano-flow liquid chromatography systems, automated sample preparation platforms, and computational analysis pipelines. Typical workflows include sample quality assessment, protein extraction, enzymatic digestion, PTM enrichment, LC-MS/MS acquisition, raw data processing, modification site identification, pathway analysis, and scientific report delivery.

From the industry chain perspective, upstream participants include mass spectrometry manufacturers, chromatography suppliers, laboratory consumable providers, biochemical reagent companies, antibody and modified peptide standard suppliers, and computational biology platform providers. The midstream consists of specialized proteomics CRO companies, multi-omics research service providers, and life science technology platforms. Downstream customers include pharmaceutical companies, biotechnology firms, universities, medical institutions, disease research centers, and agricultural biotechnology organizations.

Modified proteomics services generally achieve higher profitability than conventional protein analysis due to their technical complexity and specialized requirements. Advanced services such as phosphoproteomics, ubiquitinomics, glycoproteomics, clinical PTM profiling, and drug mechanism studies typically generate gross margins of approximately 50%-70% due to high technical barriers and complex workflows. Standardized modification analysis services generally achieve margins of around 35%-55% under stronger market competition. Companies with proprietary databases, analytical algorithms, specialized workflows, and pharmaceutical partnerships can achieve margins above 60% through technological differentiation and operational scale.

Modified proteomics services are becoming a rapidly growing segment within precision life science research. As innovative drug development moves beyond genomic information toward functional regulation at the protein level, pharmaceutical companies and research organizations increasingly require detailed insights into dynamic protein changes. Unlike genomics and transcriptomics, modified proteomics directly reveals signaling pathways, disease-related mechanisms, and therapeutic responses through analysis of protein functional states. This creates significant opportunities in oncology, immunotherapy, neurological disorders, metabolic diseases, and targeted drug development. Advances in high-sensitivity mass spectrometry, automated workflows, and AI-driven data interpretation are further expanding the commercial potential of modified proteomics services.

The modified proteomics service industry faces challenges including complex experimental workflows, high analytical costs, sophisticated data interpretation requirements, and limited standardization. Different types of protein modifications exhibit distinct chemical properties, requiring specialized enrichment strategies and analytical methods. In addition, market development may be affected by biotechnology funding cycles, drug development timelines, and research budget fluctuations. Companies need to continuously enhance technology platforms, automation capabilities, databases, and computational solutions to maintain long-term competitiveness.

Future demand for modified proteomics services will increasingly focus on clinical translation, high-throughput profiling, multi-omics integration, and AI-enabled analysis. Pharmaceutical companies will increasingly adopt modified proteomics for mechanism-of-action studies, target validation, and companion diagnostic development to improve R&D efficiency. Biotechnology companies will rely on specialized external services to reduce infrastructure investment and accelerate innovation pipelines. Research institutions and medical organizations will expand applications in disease mechanism studies, early detection, and precision treatment. As life science research becomes increasingly data-driven, service providers with advanced analytical platforms, comprehensive databases, and integrated interpretation capabilities will achieve stronger competitive advantages in the global market.

This report provides a comprehensive view of the global market for Modified Proteomics Service, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Modified Proteomics Service market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Modified Proteomics Service.

MARKET SEGMENTATION

By Company

PTM BIO
Cell Signaling Technology (CST)
APTBIO
BGI Genomics
OmicScouts (Momentum Biotechnologies)
Biodesix
Shanghai OE Biotech
Crown Bioscience
Shanghai Bioprofile
Creative Proteomics
Inotiv
MtoZ-Biolabs
CellCarta
Biognosys
MS Bioworks
Charles River Laboratories
Metware Biotechnology
Novogene
Evotec
RxCelerate
Shanghai Majorbio Bio-Pharm
Lc-Bio Technologies
CD Genomics
Discovery Life Sciences
Applied Biomics
VProteomics
Allumiqs
Westlake Omics
CDI Labs
Proteome Sciences
Sapient Bioanalytics
Proteomics International
Cosmos Wisdom
MRM Proteomics
Sinotech Genomics
Precision Biomarker Laboratories (PBL)

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Phosphorylation
Acetylation
Ubiquitination
Methylation
Glycosylation
Lactylation
Redox
Palmitoylation
Others

Segment by Application

Clinical Diagnostics
Drug Discovery
Others

Segment by Category

Universities and Research Institutes
Hospitals
Pharmaceutical Companies
Others

Segment by Division

Oncology
Cardiovascular
Agriculture
Neuroscience
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Modified Proteomics Service companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Modified Proteomics Service revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Modified Proteomics Service revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Modified Proteomics Service Product Introduction

1.2 Global Modified Proteomics Service Market Size Forecast (2021–2032)

1.3 Modified Proteomics Service Market Trends & Drivers

1.3.1 Modified Proteomics Service Industry Trends

1.3.2 Modified Proteomics Service Market Drivers & Opportunities

1.3.3 Modified Proteomics Service Market Challenges

1.3.4 Modified Proteomics Service Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Modified Proteomics Service Players Revenue Ranking (2025)

2.2 Global Modified Proteomics Service Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Modified Proteomics Service Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Modified Proteomics Service

2.6 Modified Proteomics Service Market Competitive Analysis

2.6.1 Modified Proteomics Service Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Modified Proteomics Service Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Modified Proteomics Service revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Modified Proteomics Service Market Classification

3.1 Introduction by Type

3.1.1 Phosphorylation

3.1.2 Acetylation

3.1.3 Ubiquitination

3.1.4 Methylation

3.1.5 Glycosylation

3.1.6 Lactylation

3.1.7 Redox

3.1.8 Palmitoylation

3.1.9 Others

3.1.10 Global Modified Proteomics Service Sales Value by Type

3.1.10.1 Global Modified Proteomics Service Sales Value by Type (2021 vs 2025 vs 2032)

3.1.10.2 Global Modified Proteomics Service Sales Value, by Type (2021–2032)

3.1.10.3 Global Modified Proteomics Service Sales Value, by Type (%), 2021–2032

3.2 Introduction by End User

3.2.1 Universities and Research Institutes

3.2.2 Hospitals

3.2.3 Pharmaceutical Companies

3.2.4 Others

3.2.5 Global Modified Proteomics Service Sales Value by End User

3.2.5.1 Global Modified Proteomics Service Sales Value by End User (2021 vs 2025 vs 2032)

3.2.5.2 Global Modified Proteomics Service Sales Value, by End User (2021–2032)

3.2.5.3 Global Modified Proteomics Service Sales Value, by End User (%), 2021–2032

3.3 Introduction by Research Areas

3.3.1 Oncology

3.3.2 Cardiovascular

3.3.3 Agriculture

3.3.4 Neuroscience

3.3.5 Other

3.3.6 Global Modified Proteomics Service Sales Value by Research Areas

3.3.6.1 Global Modified Proteomics Service Sales Value by Research Areas (2021 vs 2025 vs 2032)

3.3.6.2 Global Modified Proteomics Service Sales Value, by Research Areas (2021–2032)

3.3.6.3 Global Modified Proteomics Service Sales Value, by Research Areas (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Clinical Diagnostics

4.1.2 Drug Discovery

4.1.3 Others

4.2 Global Modified Proteomics Service Sales Value by Application

4.2.1 Global Modified Proteomics Service Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Modified Proteomics Service Sales Value by Application (2021–2032)

4.2.3 Global Modified Proteomics Service Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Modified Proteomics Service Sales Value by Region

5.1.1 Global Modified Proteomics Service Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Modified Proteomics Service Sales Value by Region (2021–2026)

5.1.3 Global Modified Proteomics Service Sales Value by Region (2027–2032)

5.1.4 Global Modified Proteomics Service Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Modified Proteomics Service Sales Value, 2021–2032

5.2.2 North America Modified Proteomics Service Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Modified Proteomics Service Sales Value, 2021–2032

5.3.2 Europe Modified Proteomics Service Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Modified Proteomics Service Sales Value, 2021–2032

5.4.2 Asia Pacific Modified Proteomics Service Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Modified Proteomics Service Sales Value, 2021–2032

5.5.2 South America Modified Proteomics Service Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Modified Proteomics Service Sales Value, 2021–2032

5.6.2 Middle East & Africa Modified Proteomics Service Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Modified Proteomics Service Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Modified Proteomics Service Sales Value, 2021–2032

6.3 United States

6.3.1 United States Modified Proteomics Service Sales Value, 2021–2032

6.3.2 United States Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Modified Proteomics Service Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Modified Proteomics Service Sales Value, 2021–2032

6.4.2 Europe Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Modified Proteomics Service Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Modified Proteomics Service Sales Value, 2021–2032

6.5.2 China Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.5.3 China Modified Proteomics Service Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Modified Proteomics Service Sales Value, 2021–2032

6.6.2 Japan Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Modified Proteomics Service Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Modified Proteomics Service Sales Value, 2021–2032

6.7.2 South Korea Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Modified Proteomics Service Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Modified Proteomics Service Sales Value, 2021–2032

6.8.2 Southeast Asia Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Modified Proteomics Service Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Modified Proteomics Service Sales Value, 2021–2032

6.9.2 India Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.9.3 India Modified Proteomics Service Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 PTM BIO

7.1.1 PTM BIO Profile

7.1.2 PTM BIO Main Business

7.1.3 PTM BIO Modified Proteomics Service Products, Services, and Solutions

7.1.4 PTM BIO Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.1.5 PTM BIO Recent Developments

7.2 Cell Signaling Technology (CST)

7.2.1 Cell Signaling Technology (CST) Profile

7.2.2 Cell Signaling Technology (CST) Main Business

7.2.3 Cell Signaling Technology (CST) Modified Proteomics Service Products, Services, and Solutions

7.2.4 Cell Signaling Technology (CST) Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.2.5 Cell Signaling Technology (CST) Recent Developments

7.3 APTBIO

7.3.1 APTBIO Profile

7.3.2 APTBIO Main Business

7.3.3 APTBIO Modified Proteomics Service Products, Services, and Solutions

7.3.4 APTBIO Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.3.5 APTBIO Recent Developments

7.4 BGI Genomics

7.4.1 BGI Genomics Profile

7.4.2 BGI Genomics Main Business

7.4.3 BGI Genomics Modified Proteomics Service Products, Services, and Solutions

7.4.4 BGI Genomics Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.4.5 BGI Genomics Recent Developments

7.5 OmicScouts (Momentum Biotechnologies)

7.5.1 OmicScouts (Momentum Biotechnologies) Profile

7.5.2 OmicScouts (Momentum Biotechnologies) Main Business

7.5.3 OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Products, Services, and Solutions

7.5.4 OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.5.5 OmicScouts (Momentum Biotechnologies) Recent Developments

7.6 Biodesix

7.6.1 Biodesix Profile

7.6.2 Biodesix Main Business

7.6.3 Biodesix Modified Proteomics Service Products, Services, and Solutions

7.6.4 Biodesix Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.6.5 Biodesix Recent Developments

7.7 Shanghai OE Biotech

7.7.1 Shanghai OE Biotech Profile

7.7.2 Shanghai OE Biotech Main Business

7.7.3 Shanghai OE Biotech Modified Proteomics Service Products, Services, and Solutions

7.7.4 Shanghai OE Biotech Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.7.5 Shanghai OE Biotech Recent Developments

7.8 Crown Bioscience

7.8.1 Crown Bioscience Profile

7.8.2 Crown Bioscience Main Business

7.8.3 Crown Bioscience Modified Proteomics Service Products, Services, and Solutions

7.8.4 Crown Bioscience Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.8.5 Crown Bioscience Recent Developments

7.9 Shanghai Bioprofile

7.9.1 Shanghai Bioprofile Profile

7.9.2 Shanghai Bioprofile Main Business

7.9.3 Shanghai Bioprofile Modified Proteomics Service Products, Services, and Solutions

7.9.4 Shanghai Bioprofile Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.9.5 Shanghai Bioprofile Recent Developments

7.10 Creative Proteomics

7.10.1 Creative Proteomics Profile

7.10.2 Creative Proteomics Main Business

7.10.3 Creative Proteomics Modified Proteomics Service Products, Services, and Solutions

7.10.4 Creative Proteomics Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.10.5 Creative Proteomics Recent Developments

7.11 Inotiv

7.11.1 Inotiv Profile

7.11.2 Inotiv Main Business

7.11.3 Inotiv Modified Proteomics Service Products, Services, and Solutions

7.11.4 Inotiv Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.11.5 Inotiv Recent Developments

7.12 MtoZ-Biolabs

7.12.1 MtoZ-Biolabs Profile

7.12.2 MtoZ-Biolabs Main Business

7.12.3 MtoZ-Biolabs Modified Proteomics Service Products, Services, and Solutions

7.12.4 MtoZ-Biolabs Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.12.5 MtoZ-Biolabs Recent Developments

7.13 CellCarta

7.13.1 CellCarta Profile

7.13.2 CellCarta Main Business

7.13.3 CellCarta Modified Proteomics Service Products, Services, and Solutions

7.13.4 CellCarta Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.13.5 CellCarta Recent Developments

7.14 Biognosys

7.14.1 Biognosys Profile

7.14.2 Biognosys Main Business

7.14.3 Biognosys Modified Proteomics Service Products, Services, and Solutions

7.14.4 Biognosys Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.14.5 Biognosys Recent Developments

7.15 MS Bioworks

7.15.1 MS Bioworks Profile

7.15.2 MS Bioworks Main Business

7.15.3 MS Bioworks Modified Proteomics Service Products, Services, and Solutions

7.15.4 MS Bioworks Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.15.5 MS Bioworks Recent Developments

7.16 Charles River Laboratories

7.16.1 Charles River Laboratories Profile

7.16.2 Charles River Laboratories Main Business

7.16.3 Charles River Laboratories Modified Proteomics Service Products, Services, and Solutions

7.16.4 Charles River Laboratories Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.16.5 Charles River Laboratories Recent Developments

7.17 Metware Biotechnology

7.17.1 Metware Biotechnology Profile

7.17.2 Metware Biotechnology Main Business

7.17.3 Metware Biotechnology Modified Proteomics Service Products, Services, and Solutions

7.17.4 Metware Biotechnology Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.17.5 Metware Biotechnology Recent Developments

7.18 Novogene

7.18.1 Novogene Profile

7.18.2 Novogene Main Business

7.18.3 Novogene Modified Proteomics Service Products, Services, and Solutions

7.18.4 Novogene Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.18.5 Novogene Recent Developments

7.19 Evotec

7.19.1 Evotec Profile

7.19.2 Evotec Main Business

7.19.3 Evotec Modified Proteomics Service Products, Services, and Solutions

7.19.4 Evotec Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.19.5 Evotec Recent Developments

7.20 RxCelerate

7.20.1 RxCelerate Profile

7.20.2 RxCelerate Main Business

7.20.3 RxCelerate Modified Proteomics Service Products, Services, and Solutions

7.20.4 RxCelerate Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.20.5 RxCelerate Recent Developments

7.21 Shanghai Majorbio Bio-Pharm

7.21.1 Shanghai Majorbio Bio-Pharm Profile

7.21.2 Shanghai Majorbio Bio-Pharm Main Business

7.21.3 Shanghai Majorbio Bio-Pharm Modified Proteomics Service Products, Services, and Solutions

7.21.4 Shanghai Majorbio Bio-Pharm Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.21.5 Shanghai Majorbio Bio-Pharm Recent Developments

7.22 Lc-Bio Technologies

7.22.1 Lc-Bio Technologies Profile

7.22.2 Lc-Bio Technologies Main Business

7.22.3 Lc-Bio Technologies Modified Proteomics Service Products, Services, and Solutions

7.22.4 Lc-Bio Technologies Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.22.5 Lc-Bio Technologies Recent Developments

7.23 CD Genomics

7.23.1 CD Genomics Profile

7.23.2 CD Genomics Main Business

7.23.3 CD Genomics Modified Proteomics Service Products, Services, and Solutions

7.23.4 CD Genomics Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.23.5 CD Genomics Recent Developments

7.24 Discovery Life Sciences

7.24.1 Discovery Life Sciences Profile

7.24.2 Discovery Life Sciences Main Business

7.24.3 Discovery Life Sciences Modified Proteomics Service Products, Services, and Solutions

7.24.4 Discovery Life Sciences Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.24.5 Discovery Life Sciences Recent Developments

7.25 Applied Biomics

7.25.1 Applied Biomics Profile

7.25.2 Applied Biomics Main Business

7.25.3 Applied Biomics Modified Proteomics Service Products, Services, and Solutions

7.25.4 Applied Biomics Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.25.5 Applied Biomics Recent Developments

7.26 VProteomics

7.26.1 VProteomics Profile

7.26.2 VProteomics Main Business

7.26.3 VProteomics Modified Proteomics Service Products, Services, and Solutions

7.26.4 VProteomics Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.26.5 VProteomics Recent Developments

7.27 Allumiqs

7.27.1 Allumiqs Profile

7.27.2 Allumiqs Main Business

7.27.3 Allumiqs Modified Proteomics Service Products, Services, and Solutions

7.27.4 Allumiqs Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.27.5 Allumiqs Recent Developments

7.28 Westlake Omics

7.28.1 Westlake Omics Profile

7.28.2 Westlake Omics Main Business

7.28.3 Westlake Omics Modified Proteomics Service Products, Services, and Solutions

7.28.4 Westlake Omics Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.28.5 Westlake Omics Recent Developments

7.29 CDI Labs

7.29.1 CDI Labs Profile

7.29.2 CDI Labs Main Business

7.29.3 CDI Labs Modified Proteomics Service Products, Services, and Solutions

7.29.4 CDI Labs Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.29.5 CDI Labs Recent Developments

7.30 Proteome Sciences

7.30.1 Proteome Sciences Profile

7.30.2 Proteome Sciences Main Business

7.30.3 Proteome Sciences Modified Proteomics Service Products, Services, and Solutions

7.30.4 Proteome Sciences Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.30.5 Proteome Sciences Recent Developments

7.31 Sapient Bioanalytics

7.31.1 Sapient Bioanalytics Profile

7.31.2 Sapient Bioanalytics Main Business

7.31.3 Sapient Bioanalytics Modified Proteomics Service Products, Services, and Solutions

7.31.4 Sapient Bioanalytics Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.31.5 Sapient Bioanalytics Recent Developments

7.32 Proteomics International

7.32.1 Proteomics International Profile

7.32.2 Proteomics International Main Business

7.32.3 Proteomics International Modified Proteomics Service Products, Services, and Solutions

7.32.4 Proteomics International Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.32.5 Proteomics International Recent Developments

7.33 Cosmos Wisdom

7.33.1 Cosmos Wisdom Profile

7.33.2 Cosmos Wisdom Main Business

7.33.3 Cosmos Wisdom Modified Proteomics Service Products, Services, and Solutions

7.33.4 Cosmos Wisdom Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.33.5 Cosmos Wisdom Recent Developments

7.34 MRM Proteomics

7.34.1 MRM Proteomics Profile

7.34.2 MRM Proteomics Main Business

7.34.3 MRM Proteomics Modified Proteomics Service Products, Services, and Solutions

7.34.4 MRM Proteomics Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.34.5 MRM Proteomics Recent Developments

7.35 Sinotech Genomics

7.35.1 Sinotech Genomics Profile

7.35.2 Sinotech Genomics Main Business

7.35.3 Sinotech Genomics Modified Proteomics Service Products, Services, and Solutions

7.35.4 Sinotech Genomics Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.35.5 Sinotech Genomics Recent Developments

7.36 Precision Biomarker Laboratories (PBL)

7.36.1 Precision Biomarker Laboratories (PBL) Profile

7.36.2 Precision Biomarker Laboratories (PBL) Main Business

7.36.3 Precision Biomarker Laboratories (PBL) Modified Proteomics Service Products, Services, and Solutions

7.36.4 Precision Biomarker Laboratories (PBL) Modified Proteomics Service Revenue (US$ Million), 2021–2026

7.36.5 Precision Biomarker Laboratories (PBL) Recent Developments

8 Industry Chain Analysis

8.1 Modified Proteomics Service Value Chain

8.2 Modified Proteomics Service Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Modified Proteomics Service Sales Model

8.5.2 Sales Channels

8.5.3 Modified Proteomics Service Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Modified Proteomics Service Market Trends

Table 2. Modified Proteomics Service Market Drivers & Opportunities

Table 3. Modified Proteomics Service Market Challenges

Table 4. Modified Proteomics Service Market Restraints

Table 5. Global Modified Proteomics Service Revenue by Company (US$ Million), 2021–2026

Table 6. Global Modified Proteomics Service Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Modified Proteomics Service Product Type

Table 9. Key Companies General Availability (GA) Timeline for Modified Proteomics Service

Table 10. Global Modified Proteomics Service Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Modified Proteomics Service revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Modified Proteomics Service Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Modified Proteomics Service Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Modified Proteomics Service Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Modified Proteomics Service Sales Market Share in Value by Type (2021–2026)

Table 17. Global Modified Proteomics Service Sales Market Share in Value by Type (2027–2032)

Table 18. Global Modified Proteomics Service Sales Value by End User: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Modified Proteomics Service Sales Value by End User (US$ Million), 2021–2026

Table 20. Global Modified Proteomics Service Sales Value by End User (US$ Million), 2027–2032

Table 21. Global Modified Proteomics Service Sales Market Share in Value by End User (2021–2026)

Table 22. Global Modified Proteomics Service Sales Market Share in Value by End User (2027–2032)

Table 23. Global Modified Proteomics Service Sales Value by Research Areas: 2021 vs 2025 vs 2032 (US$ Million)

Table 24. Global Modified Proteomics Service Sales Value by Research Areas (US$ Million), 2021–2026

Table 25. Global Modified Proteomics Service Sales Value by Research Areas (US$ Million), 2027–2032

Table 26. Global Modified Proteomics Service Sales Market Share in Value by Research Areas (2021–2026)

Table 27. Global Modified Proteomics Service Sales Market Share in Value by Research Areas (2027–2032)

Table 28. Global Modified Proteomics Service Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Modified Proteomics Service Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Modified Proteomics Service Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Modified Proteomics Service Sales Market Share in Value by Application (2021–2026)

Table 32. Global Modified Proteomics Service Sales Market Share in Value by Application (2027–2032)

Table 33. Global Modified Proteomics Service Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 34. Global Modified Proteomics Service Sales Value by Region (US$ Million), 2021–2026

Table 35. Global Modified Proteomics Service Sales Value by Region (US$ Million), 2027–2032

Table 36. Global Modified Proteomics Service Sales Value by Region (%), 2021–2026

Table 37. Global Modified Proteomics Service Sales Value by Region (%), 2027–2032

Table 38. Key Countries/Regions Modified Proteomics Service Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 39. Key Countries/Regions Modified Proteomics Service Sales Value, (US$ Million), 2021–2026

Table 40. Key Countries/Regions Modified Proteomics Service Sales Value, (US$ Million), 2027–2032

Table 41. PTM BIO Basic Information List

Table 42. PTM BIO Description and Business Overview

Table 43. PTM BIO Modified Proteomics Service Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Modified Proteomics Service Business of PTM BIO (2021–2026)

Table 45. PTM BIO Recent Developments

Table 46. Cell Signaling Technology (CST) Basic Information List

Table 47. Cell Signaling Technology (CST) Description and Business Overview

Table 48. Cell Signaling Technology (CST) Modified Proteomics Service Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Modified Proteomics Service Business of Cell Signaling Technology (CST) (2021–2026)

Table 50. Cell Signaling Technology (CST) Recent Developments

Table 51. APTBIO Basic Information List

Table 52. APTBIO Description and Business Overview

Table 53. APTBIO Modified Proteomics Service Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Modified Proteomics Service Business of APTBIO (2021–2026)

Table 55. APTBIO Recent Developments

Table 56. BGI Genomics Basic Information List

Table 57. BGI Genomics Description and Business Overview

Table 58. BGI Genomics Modified Proteomics Service Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Modified Proteomics Service Business of BGI Genomics (2021–2026)

Table 60. BGI Genomics Recent Developments

Table 61. OmicScouts (Momentum Biotechnologies) Basic Information List

Table 62. OmicScouts (Momentum Biotechnologies) Description and Business Overview

Table 63. OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Modified Proteomics Service Business of OmicScouts (Momentum Biotechnologies) (2021–2026)

Table 65. OmicScouts (Momentum Biotechnologies) Recent Developments

Table 66. Biodesix Basic Information List

Table 67. Biodesix Description and Business Overview

Table 68. Biodesix Modified Proteomics Service Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Modified Proteomics Service Business of Biodesix (2021–2026)

Table 70. Biodesix Recent Developments

Table 71. Shanghai OE Biotech Basic Information List

Table 72. Shanghai OE Biotech Description and Business Overview

Table 73. Shanghai OE Biotech Modified Proteomics Service Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Modified Proteomics Service Business of Shanghai OE Biotech (2021–2026)

Table 75. Shanghai OE Biotech Recent Developments

Table 76. Crown Bioscience Basic Information List

Table 77. Crown Bioscience Description and Business Overview

Table 78. Crown Bioscience Modified Proteomics Service Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Modified Proteomics Service Business of Crown Bioscience (2021–2026)

Table 80. Crown Bioscience Recent Developments

Table 81. Shanghai Bioprofile Basic Information List

Table 82. Shanghai Bioprofile Description and Business Overview

Table 83. Shanghai Bioprofile Modified Proteomics Service Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Modified Proteomics Service Business of Shanghai Bioprofile (2021–2026)

Table 85. Shanghai Bioprofile Recent Developments

Table 86. Creative Proteomics Basic Information List

Table 87. Creative Proteomics Description and Business Overview

Table 88. Creative Proteomics Modified Proteomics Service Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Modified Proteomics Service Business of Creative Proteomics (2021–2026)

Table 90. Creative Proteomics Recent Developments

Table 91. Inotiv Basic Information List

Table 92. Inotiv Description and Business Overview

Table 93. Inotiv Modified Proteomics Service Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Modified Proteomics Service Business of Inotiv (2021–2026)

Table 95. Inotiv Recent Developments

Table 96. MtoZ-Biolabs Basic Information List

Table 97. MtoZ-Biolabs Description and Business Overview

Table 98. MtoZ-Biolabs Modified Proteomics Service Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Modified Proteomics Service Business of MtoZ-Biolabs (2021–2026)

Table 100. MtoZ-Biolabs Recent Developments

Table 101. CellCarta Basic Information List

Table 102. CellCarta Description and Business Overview

Table 103. CellCarta Modified Proteomics Service Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Modified Proteomics Service Business of CellCarta (2021–2026)

Table 105. CellCarta Recent Developments

Table 106. Biognosys Basic Information List

Table 107. Biognosys Description and Business Overview

Table 108. Biognosys Modified Proteomics Service Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Modified Proteomics Service Business of Biognosys (2021–2026)

Table 110. Biognosys Recent Developments

Table 111. MS Bioworks Basic Information List

Table 112. MS Bioworks Description and Business Overview

Table 113. MS Bioworks Modified Proteomics Service Products, Services, and Solutions

Table 114. Revenue (US$ Million) in Modified Proteomics Service Business of MS Bioworks (2021–2026)

Table 115. MS Bioworks Recent Developments

Table 116. Charles River Laboratories Basic Information List

Table 117. Charles River Laboratories Description and Business Overview

Table 118. Charles River Laboratories Modified Proteomics Service Products, Services, and Solutions

Table 119. Revenue (US$ Million) in Modified Proteomics Service Business of Charles River Laboratories (2021–2026)

Table 120. Charles River Laboratories Recent Developments

Table 121. Metware Biotechnology Basic Information List

Table 122. Metware Biotechnology Description and Business Overview

Table 123. Metware Biotechnology Modified Proteomics Service Products, Services, and Solutions

Table 124. Revenue (US$ Million) in Modified Proteomics Service Business of Metware Biotechnology (2021–2026)

Table 125. Metware Biotechnology Recent Developments

Table 126. Novogene Basic Information List

Table 127. Novogene Description and Business Overview

Table 128. Novogene Modified Proteomics Service Products, Services, and Solutions

Table 129. Revenue (US$ Million) in Modified Proteomics Service Business of Novogene (2021–2026)

Table 130. Novogene Recent Developments

Table 131. Evotec Basic Information List

Table 132. Evotec Description and Business Overview

Table 133. Evotec Modified Proteomics Service Products, Services, and Solutions

Table 134. Revenue (US$ Million) in Modified Proteomics Service Business of Evotec (2021–2026)

Table 135. Evotec Recent Developments

Table 136. RxCelerate Basic Information List

Table 137. RxCelerate Description and Business Overview

Table 138. RxCelerate Modified Proteomics Service Products, Services, and Solutions

Table 139. Revenue (US$ Million) in Modified Proteomics Service Business of RxCelerate (2021–2026)

Table 140. RxCelerate Recent Developments

Table 141. Shanghai Majorbio Bio-Pharm Basic Information List

Table 142. Shanghai Majorbio Bio-Pharm Description and Business Overview

Table 143. Shanghai Majorbio Bio-Pharm Modified Proteomics Service Products, Services, and Solutions

Table 144. Revenue (US$ Million) in Modified Proteomics Service Business of Shanghai Majorbio Bio-Pharm (2021–2026)

Table 145. Shanghai Majorbio Bio-Pharm Recent Developments

Table 146. Lc-Bio Technologies Basic Information List

Table 147. Lc-Bio Technologies Description and Business Overview

Table 148. Lc-Bio Technologies Modified Proteomics Service Products, Services, and Solutions

Table 149. Revenue (US$ Million) in Modified Proteomics Service Business of Lc-Bio Technologies (2021–2026)

Table 150. Lc-Bio Technologies Recent Developments

Table 151. CD Genomics Basic Information List

Table 152. CD Genomics Description and Business Overview

Table 153. CD Genomics Modified Proteomics Service Products, Services, and Solutions

Table 154. Revenue (US$ Million) in Modified Proteomics Service Business of CD Genomics (2021–2026)

Table 155. CD Genomics Recent Developments

Table 156. Discovery Life Sciences Basic Information List

Table 157. Discovery Life Sciences Description and Business Overview

Table 158. Discovery Life Sciences Modified Proteomics Service Products, Services, and Solutions

Table 159. Revenue (US$ Million) in Modified Proteomics Service Business of Discovery Life Sciences (2021–2026)

Table 160. Discovery Life Sciences Recent Developments

Table 161. Applied Biomics Basic Information List

Table 162. Applied Biomics Description and Business Overview

Table 163. Applied Biomics Modified Proteomics Service Products, Services, and Solutions

Table 164. Revenue (US$ Million) in Modified Proteomics Service Business of Applied Biomics (2021–2026)

Table 165. Applied Biomics Recent Developments

Table 166. VProteomics Basic Information List

Table 167. VProteomics Description and Business Overview

Table 168. VProteomics Modified Proteomics Service Products, Services, and Solutions

Table 169. Revenue (US$ Million) in Modified Proteomics Service Business of VProteomics (2021–2026)

Table 170. VProteomics Recent Developments

Table 171. Allumiqs Basic Information List

Table 172. Allumiqs Description and Business Overview

Table 173. Allumiqs Modified Proteomics Service Products, Services, and Solutions

Table 174. Revenue (US$ Million) in Modified Proteomics Service Business of Allumiqs (2021–2026)

Table 175. Allumiqs Recent Developments

Table 176. Westlake Omics Basic Information List

Table 177. Westlake Omics Description and Business Overview

Table 178. Westlake Omics Modified Proteomics Service Products, Services, and Solutions

Table 179. Revenue (US$ Million) in Modified Proteomics Service Business of Westlake Omics (2021–2026)

Table 180. Westlake Omics Recent Developments

Table 181. CDI Labs Basic Information List

Table 182. CDI Labs Description and Business Overview

Table 183. CDI Labs Modified Proteomics Service Products, Services, and Solutions

Table 184. Revenue (US$ Million) in Modified Proteomics Service Business of CDI Labs (2021–2026)

Table 185. CDI Labs Recent Developments

Table 186. Proteome Sciences Basic Information List

Table 187. Proteome Sciences Description and Business Overview

Table 188. Proteome Sciences Modified Proteomics Service Products, Services, and Solutions

Table 189. Revenue (US$ Million) in Modified Proteomics Service Business of Proteome Sciences (2021–2026)

Table 190. Proteome Sciences Recent Developments

Table 191. Sapient Bioanalytics Basic Information List

Table 192. Sapient Bioanalytics Description and Business Overview

Table 193. Sapient Bioanalytics Modified Proteomics Service Products, Services, and Solutions

Table 194. Revenue (US$ Million) in Modified Proteomics Service Business of Sapient Bioanalytics (2021–2026)

Table 195. Sapient Bioanalytics Recent Developments

Table 196. Proteomics International Basic Information List

Table 197. Proteomics International Description and Business Overview

Table 198. Proteomics International Modified Proteomics Service Products, Services, and Solutions

Table 199. Revenue (US$ Million) in Modified Proteomics Service Business of Proteomics International (2021–2026)

Table 200. Proteomics International Recent Developments

Table 201. Cosmos Wisdom Basic Information List

Table 202. Cosmos Wisdom Description and Business Overview

Table 203. Cosmos Wisdom Modified Proteomics Service Products, Services, and Solutions

Table 204. Revenue (US$ Million) in Modified Proteomics Service Business of Cosmos Wisdom (2021–2026)

Table 205. Cosmos Wisdom Recent Developments

Table 206. MRM Proteomics Basic Information List

Table 207. MRM Proteomics Description and Business Overview

Table 208. MRM Proteomics Modified Proteomics Service Products, Services, and Solutions

Table 209. Revenue (US$ Million) in Modified Proteomics Service Business of MRM Proteomics (2021–2026)

Table 210. MRM Proteomics Recent Developments

Table 211. Sinotech Genomics Basic Information List

Table 212. Sinotech Genomics Description and Business Overview

Table 213. Sinotech Genomics Modified Proteomics Service Products, Services, and Solutions

Table 214. Revenue (US$ Million) in Modified Proteomics Service Business of Sinotech Genomics (2021–2026)

Table 215. Sinotech Genomics Recent Developments

Table 216. Precision Biomarker Laboratories (PBL) Basic Information List

Table 217. Precision Biomarker Laboratories (PBL) Description and Business Overview

Table 218. Precision Biomarker Laboratories (PBL) Modified Proteomics Service Products, Services, and Solutions

Table 219. Revenue (US$ Million) in Modified Proteomics Service Business of Precision Biomarker Laboratories (PBL) (2021–2026)

Table 220. Precision Biomarker Laboratories (PBL) Recent Developments

Table 221. Revenue (US$ Million) in Modified Proteomics Service Business of Company 40 (2021–2026)

Table 222. Company 40 Recent Developments

Table 223. Key Raw Materials Lists

Table 224. Key Suppliers of Raw Materials Lists

Table 225. Modified Proteomics Service Downstream Customers

Table 226. Modified Proteomics Service Distributors List

Table 227. Research Programs/Design for This Report

Table 228. Key Data Information from Secondary Sources

Table 229. Key Data Information from Primary Sources

List of Figures

Figure 1. Modified Proteomics Service Product Picture

Figure 2. Global Modified Proteomics Service Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Modified Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 4. Modified Proteomics Service Report Years Considered

Figure 5. Global Modified Proteomics Service Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Modified Proteomics Service Revenue in 2025

Figure 7. Modified Proteomics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Phosphorylation Picture

Figure 9. Acetylation Picture

Figure 10. Ubiquitination Picture

Figure 11. Methylation Picture

Figure 12. Glycosylation Picture

Figure 13. Lactylation Picture

Figure 14. Redox Picture

Figure 15. Palmitoylation Picture

Figure 16. Others Picture

Figure 17. Global Modified Proteomics Service Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Modified Proteomics Service Sales Value Market Share by Type, 2025 & 2032

Figure 19. Universities and Research Institutes Picture

Figure 20. Hospitals Picture

Figure 21. Pharmaceutical Companies Picture

Figure 22. Others Picture

Figure 23. Global Modified Proteomics Service Sales Value by End User (US$ Million), 2021 vs 2025 vs 2032

Figure 24. Global Modified Proteomics Service Sales Value Market Share by End User, 2025 & 2032

Figure 25. Oncology Picture

Figure 26. Cardiovascular Picture

Figure 27. Agriculture Picture

Figure 28. Neuroscience Picture

Figure 29. Other Picture

Figure 30. Global Modified Proteomics Service Sales Value by Research Areas (US$ Million), 2021 vs 2025 vs 2032

Figure 31. Global Modified Proteomics Service Sales Value Market Share by Research Areas, 2025 & 2032

Figure 32. Product Picture of Clinical Diagnostics

Figure 33. Product Picture of Drug Discovery

Figure 34. Product Picture of Others

Figure 35. Global Modified Proteomics Service Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 36. Global Modified Proteomics Service Sales Value Market Share by Application, 2025 & 2032

Figure 37. North America Modified Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 38. North America Modified Proteomics Service Sales Value by Country (%), 2025 vs 2032

Figure 39. Europe Modified Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 40. Europe Modified Proteomics Service Sales Value by Country (%), 2025 vs 2032

Figure 41. Asia Pacific Modified Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 42. Asia Pacific Modified Proteomics Service Sales Value by Subregion (%), 2025 vs 2032

Figure 43. South America Modified Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 44. South America Modified Proteomics Service Sales Value by Country (%), 2025 vs 2032

Figure 45. Middle East & Africa Modified Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 46. Middle East & Africa Modified Proteomics Service Sales Value by Country (%), 2025 vs 2032

Figure 47. Key Countries/Regions Modified Proteomics Service Sales Value (%), 2021–2032

Figure 48. United States Modified Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 49. United States Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 50. United States Modified Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 51. Europe Modified Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 52. Europe Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 53. Europe Modified Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 54. China Modified Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 55. China Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 56. China Modified Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 57. Japan Modified Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 58. Japan Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 59. Japan Modified Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 60. South Korea Modified Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 61. South Korea Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 62. South Korea Modified Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 63. Southeast Asia Modified Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 64. Southeast Asia Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 65. Southeast Asia Modified Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 66. India Modified Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 67. India Modified Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 68. India Modified Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 69. Modified Proteomics Service Value Chain

Figure 70. Modified Proteomics Service Cost Structure

Figure 71. Channels of Distribution (Direct Sales, and Distribution)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Modified Proteomics Service in 2026? zhanKai

The global market size of Modified Proteomics Service in 2026 was 915 Million USD.

Which companies rank high in the global Modified Proteomics Service market? shouQi

What is the annual compound growth rate of the global Modified Proteomics Service market size from 2026 to 2032? shouQi

What was the global market size of Modified Proteomics Service in 2032? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Modified Proteomics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Modified Proteomics Service market size was US$ 854 million in 2025 and is forecast to reach a readjusted size of US$ 1554 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published Date: 2026-07-17
Pages: 184
USD 4250.00
(Single User License)
Global Modified Proteomics Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Modified Proteomics Service market is projected to grow from US$ 854 million in 2025 to US$ 1554 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-17
Pages: 194
USD 4900.00
(Single User License)
Global Modified Proteomics Service Market Research Report 2026
The global Modified Proteomics Service market was valued at US$ 854 million in 2025 and is anticipated to reach US$ 1554 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-07-17
Pages: 209
USD 2900.00
(Single User License)

Global Modified Proteomics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Modified Proteomics Service market size was US$ 854 million in 2025 and is forecast to reach a readjusted size of US$ 1554 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published: 2026-07-17
Pages: 184
USD 4250.00 (Single User License)
Global Modified Proteomics Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Modified Proteomics Service market is projected to grow from US$ 854 million in 2025 to US$ 1554 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-17
Pages: 194
USD 4900.00 (Single User License)
Global Modified Proteomics Service Market Research Report 2026
The global Modified Proteomics Service market was valued at US$ 854 million in 2025 and is anticipated to reach US$ 1554 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-07-17
Pages: 209
USD 2900.00 (Single User License)